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Objective: to investigate the concurrent validity between 
the action research arm test (arat) and the Wolf motor 
Function test (WmFt) and to compare their reproducibi­
lity, internal consistency and floor and ceiling effects in the 
same sample of stroke patients.
Methods: Forty patients participated in this study. Concur­
rent validity was determined with Spearman’s rank cor­
relation coefficients. Reproducibility was assessed with in­
traclass correlation coefficients (ICCs) and Bland-Altman 
plots, internal consistency by means of Cronbach’s alphas, 
and floor and ceiling effects were considered to be present 
if more than 20% of patients fell outside a preliminary set 
lower and upper boundary.
Results: Spearman’s rank correlation coefficients ranged 
from 0.70 to 0.86. iCCs for inter­rater and intra­rater reli­
ability ranged from 0.92 to 0.97. Bland-Altman plots showed 
a less stable way of scoring for the WmFt, compared with 
the arat. Cronbach’s alpha was > 0.98 for both scales. no 
floor and ceiling effects were found. 
Conclusion: the present study showed good clinimetric 
properties for both assessments. the high concurrent valid­
ity suggests that ARAT and WMFT have significant over­
lap with regard to the underlying construct that is being 
measured.
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INTRODUCTION
A large number of assessments for upper extremity (UE) 
function after stroke have been published in the literature (1). 
However, they vary considerably in their focus, and a golden 
standard is lacking. As a consequence, the selection of a proper 
instrument is a complex process.
Despite the multitude of assessments for UE function after 
stroke, only a few valid and reliable clinical measurement tools 
are available to quantify UE function during the performance of 
unilateral motor tasks. The Action Research Arm Test (ARAT) 
(2, 3) and the Wolf Motor Function Test (WMFT) (4) both aim 
to do this. The clinimetric properties of both measures have 
been well established (3, 5–7). However, some limitations have 
also been described. For example, it has been suggested that 
there is an ambiguity in the way in which performance could 
be scored on the ARAT, which might lead to an important 
source of uncontrolled variation between observers or between 
clinical centres (8). Standardized guidelines need to be applied 
to reduce this variation (9). In addition, both instruments are 
often criticized regarding item redundancy (10, 11) and the 
presence of floor and ceiling effects (5). Finally, although both 
instruments attempt to provide an objective measure of UE 
function, it is unclear whether they can distinguish between 
restitution of function and compensation (12).
In order to provide clinicians and researchers a basis for the 
selection of an assessment instrument, the purpose of this study 
was to investigate the concurrent validity of ARAT and WMFT 
and to compare the reproducibility, internal consistency and 
floor and ceiling effects of both instruments in the same group 
of stroke patients. The outcomes measured with the ARAT are 
expected to be consistent with the WMFT outcomes. 
METHODS
Subjects
Forty patients diagnosed with stroke were recruited from 2 rehabilita-
tion centres in the Netherlands. Inclusion criteria were: (i) hemiparesis 
of the UE, with at least some voluntary muscle contraction (Medical 
Research Council (MRC) score ≥ 1); (ii) no severe deficits in commu-
nication, memory and understanding (Mini Mental State Examination 
(MMSE) score > 22); (iii) absence of orthopaedic UE limitations. The 
protocol was approved by the local ethics committees, and all patients 
gave written informed consent. 
Outcome measures
The ARAT consists of 19 tasks, which are categorized into 4 domains 
(grasp, grip, pinch and gross movements) (2). Quality of movement is 
scored on a 4-point scale (0 = can perform no part of the test, 3 = per-
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forms test normally). The standardized method for scoring, deve loped 
by Yozbatiran et al. was used (9).
The WMFT consists of 17 items (6 joint-segment movements, 9 
integrative functional movements and 2 strength items). Performance 
time of every item is measured between a precisely defined start- and 
end-point for each task with a maximum of 120 s. The WMFT also 
contains a 6-point Functional Ability Scale (FAS) that rates the quality 
of movement and has values ranging from 0 (no attempt made to use 
the more affected UE) to 5 (movement appears to be normal) (4).
Procedures
The patients recruited from the first rehabilitation centre (n = 18) 
participated in testing the reproducibility of both ARAT and WMFT. 
Both observers applied the measurements within one week to minimize 
the effect of spontaneous recovery. The subjects were assessed by 
both observers in random order. For intra-rater reliability, the same 
sample of 18 was observed twice by one observer, approximately 10 
days apart.
Data from all 40 subjects were used to investigate internal consistency, 
concurrent validity and floor and ceiling effects of the WMFT and the 
ARAT. All assessments were executed by a trained observer in random 
order. To prevent the influence of fatigue on the results, a minimum break 
of 30 min physical rest was taken between the two tests. 
Statistical analysis
Reproducibility was assessed by means of reliability and agreement 
(13). The inter- and intra-rater reliability for the total scores of both 
measures was analysed with the intraclass correlation coefficient 
(ICC). For the inter-rater reliability a 2-way random effects model 
with absolute agreement definition was used (14). The intra-rater reli-
ability was determined by applying a 2-way mixed effects model with 
absolute agreement definition (14). ICCs were interpreted according 
to the classification of Fleiss (15). Agreement was assessed by means 
of the limits of agreement using the Bland & Altman method (16). 
Cronbach’s alpha with corresponding confidence intervals (CI) were 
calculated to determine the internal consistency between the items of 
each scale. A Cronbach’s alpha between 0.70 and 0.95 was considered 
satisfactory (17). Floor and ceiling effects were defined by means of 
the percentage of the subjects who scored beyond the lower or upper 
bound, respectively, of the total possible score. Cut-offs for floor and 
ceiling effects were set at 5% of the total score. As a consequence, 
scores below 3 points and scores above 54 points on the ARAT were 
determined as a floor and/or ceiling effect, respectively. For the 
WMFT the cut-off points were below 4 points and above 71 points, 
respectively. Significant floor and ceiling effects were considered to 
be present if more than 20% of the patients fell outside the lower or 
upper bound, respectively (18).
To determine the concurrent validity, Spearman’s rank correlation 
coefficients (rs) were calculated between the ARAT total score and the 
WMFT score, which was split into 4 variables: FAS score, median 
time score, item 7 and 14 (strength). A correlation coefficient ≥ 0.7 
was considered to reflect high concurrent validity (19). All tests were 
applied 2-tailed with a level of significance of 0.05. 
RESULTS
Patient characteristics are summarized in Table I. ICCs for inter-
rater reliability of the ARAT and the WMFT were 0.92 and 0.94, 
respectively. The intra-rater ICCs were 0.97 and 0.95 for the 
ARAT and the WMFT, respectively.
The Bland-Altman plots (Fig. 1) showed higher limits of 
agreement in the between-observer plot of both assessments, 
suggesting a lower agreement between observers than within an 
observer. The within-observer plots reflect a less stable way of 
scoring for the WMFT, compared with the ARAT. Cronbach’s 
alpha for the ARAT and the WMFT FAS were 0.985 (CI: 
0.977–0.991) and 0.982 (CI: 0.972–0.989), respectively. No 
significant floor and ceiling effects were found. On both tests, 
approximately 17% of the patients scored beyond the upper 
5% limits. Below the lower 5% limits was scored by 12.5% 
and by 5% on the ARAT and WMFT respectively.
The spearman correlation coefficient (rs) between the ARAT 
total score and the total WMFT FAS was 0.86 (p < 0.01) and 
between the ARAT score and the WMFT median time score 
was –0.89 (p < 0.01). Finally, both strength tasks of the WMFT 
(i.e. items 7 and 14) showed a correlation coefficient rs of 0.70 
(p < 0.01) with the ARAT. 
DISCUSSION
The main findings of the present study are that both assessments 
show excellent inter- and intra-observer reliability and are 
highly correlated with each other. However, the Bland-Altman 
plots showed that the between-observer agreement of both 
instruments was lower than the within-observer agreement, 
confirming that there still might be an ambiguity in the way 
in which performance could be scored and that proper training 
of observers is important for uniform application of the tests. 
Additionally, the within-observer plots showed a less stable 
way of scoring for the WMFT, suggesting a relatively higher 
measurement error for the WMFT. 
Our results showed Cronbach’s alpha’s of 0.98 or higher for 
both scales, which is consistent with previous findings of high 
internal consistency (6, 10). This suggests that both assess-
ments measure a single, unidimensional construct. However, 
an alpha-score of 0.98 could also suggest item redundancy. A 
challenge for future studies is to include more stroke patients 
in order to determine whether the number of items of each test 
can be reduced following an item-response theory model and 
to further investigate the dimensionality of both tests.
In contrast to claims from the literature (5, 10), floor and 
ceiling effects were not found in either instrument. This may 
have been caused by the fact we included mainly patients 
with mild to moderate hemiparesis. However, for this group, 
the evaluation and quantification of upper limb function is 
most relevant. 
Table I. Patient characteristics (n = 40)
Characteristic
Sex, M/F, n 23/17
Age, years, mean (SD) [range] 60.0 (13.6) [31–82]
Side of hemiplegia, L/R, n 23/17
MRC score (0–5), median (IQR) 4.0 (4–5)
Time since stroke onset in years, median (IQR) 0.41 (0.25–0.77)
ARAT total score, median (IQR) 38 (22–46)
WMFT median time in s, median (IQR) 3.29 (2.31–5.91)
WMFT FAS, median (IQR) 53 (32.75–67.75)
M/F: male/female; SD: standard deviation; L/R: left/right; MRC: 
Medical Research Council (muscle power); MMSE, Mini Mental State 
Examination; ARAT: Action Research Arm Test; WMFT: Wolf Motor 
Function Test; FAS: Functional Ability Score; IQR: interquartile 
ranges.
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The high concurrent validity between both tests suggests that 
ARAT and WMFT have significant overlap with regard to the 
underlying construct that is being measured. Unfortunately, 
based on our results no direct insight into the nature of the 
underlying construct that both assessments are assumed to 
quantify can be given. However, because of the large number 
of instruments, knowledge concerning their underlying con-
struct is needed in order to compare them and to classify them 
meaningfully. The International Classification of Functioning, 
Disability and Health (ICF) (20) can facilitate classification 
of a measurement instrument in what it does and does not 
intend to assess, by making a distinction between the domains 
of Body Functions and Structure, Activity and Participation. 
The ARAT and the WMFT can be distinguished from most 
other tests since they both intend to assess unilateral perform-
ance on functional tasks as well as gross movements of the 
upper paretic limb. However, to determine exactly what both 
assessments measure, we need to improve our understand-
ing of the required motor performance and coordination to 
execute items on the WMFT and ARAT. Future studies should 
implement electromyography and kinematic analysis in order 
to distinguish between restitution of function and the use 
of compensation strategies (12, 21). Monitoring of parallel 
changes in test scores and actual (kinematic) performance in 
a longitudinal manner will shed light on what actually changes 
during functional recovery (21).
Some limitations of the present study should be noted. First, 
this study was based on a modest sample size. Secondly, only 
patients with mild to moderate disease severity were included in 
this study. This obviously limits the generalization of the present 
findings to other patients with different characteristics.
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Fig. 1. Graphic representation according to the Bland-Altman technique. 
The dashed bold lines represent the mean difference score. The dashed 
lines represent the limits of agreement (mean ± 1.96 × the standard deviation 
of the difference score). ARAT: Action Research Arm Test  total score; 
WMFT: Wolf Motor Function Test total functional ability score.
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